Blimet Pharma Private Limited - Company Profile

It is a business services private limited company based in Aurangabad, Maharashtra, India, established in 2018.
2018 Aurangabad, Maharashtra, India Active
Last Updated:
Access Report
About Blimet Pharma Private Limited

Blimet Pharma Private Limited, a active private limited company, was established on 01 November 2018 in Aurangabad, Maharashtra, India. Engaging in miscellaneous business activities within the business services sector, it holds CIN: U74999MH2018PTC316708. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Akshay Diliprao Kadam (Director), Nitin Sahebrao Pawar (Director), Saraswati Datarav Khedkar (Director). Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at Plot No 94, Behind Cidco Office Cidco Growth Center,, Aurangabad, Maharashtra, 431136.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999MH2018PTC316708

  • Registration Number

    316708

  • Incorporation Date

    01 November 2018

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Year, 3 Months
  • Last Filing with ROC 31 Mar 2021
  • Revenue Growth **** %
  • Net Worth 42.41%
  • Total Assets **** 243.91%
Company report

Blimet Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Blimet Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Blimet Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Akshay Diliprao Kadam Director 01 Nov 2018 Current
Nitin Sahebrao Pawar Director 01 Nov 2018 Current
Saraswati Datarav Khedkar Director 01 Nov 2018 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Blimet Pharma.

Blimet Pharma Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 42.41%.

Blimet Pharma revenue growth over time
Blimet Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 243.91%
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
 42.41%
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Blimet Pharma?

Unlock access to Blimet Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Blimet Pharma?

Unlock and access historical data on people associated with Blimet Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Blimet Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Blimet Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Blimet Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Blimet Pharma Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was completed.

  • Balance Sheet

    Blimet Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    Progress on Akshay Diliprao Kadam was appointed as a Director was appointed as a Director on 01 Nov 2018 & has been associated with this company since 7 years 3 months . was documented.

  • Director Appointment

    Nitin Sahebrao Pawar was appointed as a Director was appointed as a Director on 01 Nov 2018 & has been associated with this company since 7 years 3 months . was recorded as a recent event.

  • Director Appointment

    Progress on Saraswati Datarav Khedkar was appointed as a Director was appointed as a Director on 01 Nov 2018 & has been associated with this company since 7 years 3 months . was documented.

  • Company Incorporation

    Progress on Blimet Pharma Private Limited was registered on 01 Nov 2018 with Roc Mumbai & aged 7 years 3 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Blimet Pharma Private Limited?

The CIN of Blimet Pharma Private Limited is U74999MH2018PTC316708.

Where is Blimet Pharma Private Limited headquartered?

Blimet Pharma Private Limited is headquartered at Plot No 94, Behind Cidco Office Cidco Growth Center,, Aurangabad, Maharashtra, 431136.

When was Blimet Pharma Private Limited incorporated?

Blimet Pharma Private Limited was incorporated on 01 November 2018.

Who are the current directors of Blimet Pharma Private Limited?

The current directors of Blimet Pharma Private Limited are

What is the primary industry of Blimet Pharma Private Limited?

The primary industry of Blimet Pharma Private Limited is Business Services.

Is Blimet Pharma Private Limited a listed company?

Blimet Pharma Private Limited is unlisted.

What is the capital structure of Blimet Pharma Private Limited?

The authorized capital of Blimet Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available